Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 274 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR FDA Approves Ivosidenib for Advanced or Metastatic Cholangiocarcinoma August 30, 2021 COVID-19 Vaccine: Distribution and Administration January 25, 2021 Two-Step Approach Might Be An Alternative to Standard Three-Step Approach of... December 6, 2022 FDA Grants Accelerated Approval to Tepotinib for Metastatic NSCLC February 5, 2021 Load more HOT NEWS CancerLand Bookshelf : Loosen Can Chemotherapy Drugs Be Designed to Avoid Side Effects? The future of research: meet three of our scientists working on... Acalabrutinib-Venetoclax With or Without Obinutuzumab Significantly Prolongs PFS in Fit Patients...
